Stock AASTROM BIOSCIENCES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Aastrom Biosciences Inc Nasdaq

Equities

US00253U3059

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Aastrom Biosciences Inc
04-19 Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing MT
03-15 Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing MT

Chart calendar Aastrom Biosciences Inc

d04ced3f6bd93ef4bfd74863dccd8f9b.P9AvcrcVrkMFriS25rCCEb0zit3jynJijDADp3rnGNo.SOhWS89jmnJk5mD8i-jgV_Z65K2bkhxQx10x8jGBcu17nBs02yTcOzOeYQ~ed7eb5da17e3e7beba96ea1177563798

Upcoming events on Aastrom Biosciences Inc

08/05/2024 12:55 Q1 2024 Earnings Release
08/05/2024 13:30 Q1 2024 Earnings Call
30/07/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
03/03/2025 Q4 2024 Earnings Release (Projected)
12/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Aastrom Biosciences Inc

01/05/2024 14:00 Annual General Meeting
05/03/2024 16:10 TD Cowen Health Care Conference
29/02/2024 13:30 Q4 2023 Earnings Call
29/02/2024 12:55 Q4 2023 Earnings Release
12/02/2024 16:00 Canaccord Genuity Musculoskeletal Conference
10/01/2024 15:30 JPMorgan Healthcare Conference
15/11/2023 15:00 Stephens Investment Conference
08/11/2023 13:30 Q3 2023 Earnings Call
08/11/2023 12:55 Q3 2023 Earnings Release
12/09/2023 12:30 Morgan Stanley Global Healthcare Conference
02/08/2023 13:30 Q2 2023 Earnings Call
02/08/2023 12:55 Q2 2023 Earnings Release
10/05/2023 13:30 Q1 2023 Earnings Call
10/05/2023 12:55 Q1 2023 Earnings Release
03/05/2023 14:00 Annual General Meeting
07/03/2023 17:30 Canaccord Genuity Musculoskeletal Conference
23/02/2023 13:30 FY 2022 Earnings Call
23/02/2023 12:55 FY 2022 Earnings Release
11/01/2023 15:30 JP Morgan Healthcare Conference
17/11/2022 16:00 Stephens Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		118
117
0.35%		124
124
0.17%		156
157
-0.32%		164
165
-0.16%		198
197
0.01%
239

EBITDA
Million USD		Released
Forecast
Spread 		-9,51
-10,5
9.46%		18,6
16,7
10.99%		29,5
32,0
-7.86%		24,2
22,6
6.9%		33,9
30,7
10.29%
48,5

EBIT
Million USD		Released
Forecast
Spread 		-11,3
-11,5
2.23%		2,37
0,04
6354.42%		-7,85
-5,61
-39.94%		-17,1
-21,4
20.3%		-6,46
-10,2
36.88%
5,36

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,67
-10,3
5.89%		3,04
1,05
190.64%		-7,58
-4,23
-79.37%		-16,0
-20,8
23.27%		-2,37
-7,32
67.65%
6,72

Net income
Million USD		Released
Forecast
Spread 		-9,67
-10,4
6.9%		2,86
0,49
479.46%		-7,47
-5,39
-38.6%		-16,7
-20,9
20.12%		-3,18
-7,63
58.28%
4,27

EPS
USD		Released
Forecast
Spread 		-0,22
-0,23
5.04%		0,06
0,01
700%		-0,16
-0,12
-37.93%		-0,35
-0,44
21.17%		-0,07
-0,16
56.25%
0,08

Announcement Date25/02/2024/02/2124/02/2223/02/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		47,6
48,1
-1.03%		36,1
34,3
5.16%		37,0
38,3
-3.39%		38,6
39,9
-3.38%		52,7
53,0
-0.5%		41,0
37,4
9.76%		45,9
42,1
9%		45,6
45,1
0.96%		65,0
65,0
0.03%
49,1


54,3


57,0


78,8


60,3

EBITDA
Million USD		Released
Forecast
Spread 		12,8
15,3
-16.54%		3,24
4,14
-21.71%		2,77
5,20
-46.7%		3,33
6,08
-45.32%		14,9
13,4
10.85%		1,70
4,72
-63.96%		4,44
2,52
76.11%		5,44
4,31
26.25%		22,3
19,1
16.56%
4,74


7,17


8,49


28,1


11,2

EBIT
Million USD		Released
Forecast
Spread 		4,14
6,39
-35.15%		-7,27
-4,55
-59.84%		-9,08
-5,95
-52.59%		-6,79
-4,91
-38.37%		6,09
1,74
249.15%		-8,18
-7,51
-8.87%		-5,96
-7,36
19.04%		-5,06
-6,15
17.71%		12,7
9,00
41.42%
-5,49


-2,68


-1,49


15,0


-0,25

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		4,21
7,57
-44.38%		-7,09
-4,21
-68.31%		-8,96
-5,87
-52.76%		-6,56
-4,73
-38.69%		6,62
1,77
274%		-7,50
-7,41
-1.09%		-5,02
-7,75
35.2%		-3,95
-5,99
34.12%		14,1
9,20
53.25%
-5,17


-2,33


-1,14


15,4


0,09

Net income
Million USD		Released
Forecast
Spread 		4,54
6,60
-31.24%		-7,09
-3,79
-86.99%		-8,96
-5,79
-54.89%		-6,58
-4,84
-35.96%		5,92
1,72
244.18%		-7,50
-7,41
-1.09%		-5,02
-7,29
31.1%		-3,66
-5,75
36.38%		13,0
8,59
51.3%
-5,33


-2,65


-1,07


13,3


-0,08

EPS
USD		Released
Forecast
Spread 		0,09
0,14
-34.78%		-0,15
-0,12
-28.57%		-0,19
-0,12
-55.74%		-0,14
-0,10
-37.25%		0,13
0,04
261.11%		-0,16
-0,15
-4.35%		-0,11
-0,15
27.63%		-0,08
-0,12
34.25%		0,26
0,17
54.76%
-0,11


-0,06


-0,02


0,26


-0,03

Announcement Date24/02/2204/05/2203/08/2209/11/2223/02/2310/05/2302/08/2308/11/2329/02/24-----

Upcoming sector events for Aastrom Biosciences Inc

Today 12:00 AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release
06/05/2024 BIOTEST AG: Q1 2024 Earnings Release
06/05/2024 AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024 APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
07/05/2024 07:00 BIOGAIA AB: Q1 2024 Earnings Release
07/05/2024 12:30 INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release
07/05/2024 CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
07/05/2024 ZAI LAB LIMITED: Q1 2024 Earnings Release
08/05/2024 12:55 VERICEL CORPORATION: Q1 2024 Earnings Release
08/05/2024 NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release
More events

Past sector events for Aastrom Biosciences Inc

02/05/2024 21:05 TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release
02/05/2024 12:50 ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release
02/05/2024 12:30 BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release
01/05/2024 SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release
30/04/2024 12:00 INCYTE CORPORATION: Q1 2024 Earnings Release
29/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release
29/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release
29/04/2024 22:53 SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release
28/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. VCEL Stock
  4. Stock
  5. Calendar Aastrom Biosciences Inc